Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Anywhere Real Estate | HOUS | Nov 13, 2024 | 4.05 | +5.74 |
Aon | AON | Nov 13, 2024 | 386.92 | +0.85 |
APA | APA | Nov 13, 2024 | 22.02 | +0.69 |
Apartment Investment and Management | AIV | Nov 13, 2024 | 8.61 | 0.00 |
Apellis Pharmaceuticals | APLS | Nov 13, 2024 | 28.25 | -3.45 |
APi Group | APG | Nov 13, 2024 | 36.52 | -1.19 |
Apogee Enterprises | APOG | Nov 13, 2024 | 84.78 | -0.55 |
Apogee Therapeutics | APGE | Nov 13, 2024 | 52.79 | -7.95 |
Apollo Commercial Real Estate Finance | ARI | Nov 13, 2024 | 9.13 | +0.55 |
Apollo Global Management | APO | Nov 13, 2024 | 164.34 | +0.36 |
Apollomics A | APLM | Nov 13, 2024 | 0.11 | -8.94 |
AppFolio A | APPF | Nov 13, 2024 | 234.30 | -0.41 |
Appian A | APPN | Nov 13, 2024 | 39.95 | -0.03 |
Apple | AAPL | Nov 13, 2024 | 225.12 | +0.40 |
Apple Hospitality REIT | APLE | Nov 13, 2024 | 15.89 | -0.06 |
Applied Digital | APLD | Nov 13, 2024 | 7.17 | -5.53 |
Applied DNA Sciences | APDN | Nov 13, 2024 | 0.18 | -2.57 |
Applied Industrial Technologies | AIT | Nov 13, 2024 | 271.62 | -0.83 |
Applied Materials | AMAT | Nov 13, 2024 | 182.79 | -2.05 |
Applied Optoelectronics | AAOI | Nov 13, 2024 | 27.26 | -4.48 |
Applied Therapeutics | APLT | Nov 13, 2024 | 8.92 | -9.90 |
Applovin A | APP | Nov 13, 2024 | 283.96 | -1.75 |
AppTech Payments | APCX | Nov 13, 2024 | 0.57 | -13.90 |
Aprea Therapeutics | APRE | Nov 13, 2024 | 3.30 | -3.81 |
AptarGroup | ATR | Nov 13, 2024 | 175.50 | -0.11 |
Aptevo Therapeutics | APVO | Nov 13, 2024 | 0.24 | -11.64 |
Aptiv | APTV | Nov 13, 2024 | 56.14 | -0.43 |
Aptorum Group A | APM | Nov 13, 2024 | 1.20 | 0.00 |
Aptose Biosciences | APTO | Nov 13, 2024 | 0.38 | -2.69 |
APx Acquisition I A | APXI | Nov 13, 2024 | 11.80 | -0.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.